已入深夜,您辛苦了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!祝你早点完成任务,早点休息,好梦!

Patients’ profile, burden of disease and quality of life in recurrent herpes labialis: a survey conducted in USA and France

医学 生活质量(医疗保健) 疾病 儿科 人口学 内科学 社会学 护理部
作者
Brigitte Dréno,Jean-Elie Malkin,Philippe Saïag,S. Batuji‐Garin
出处
期刊:Journal of The European Academy of Dermatology and Venereology [Wiley]
卷期号:26 (11): 1458-1460 被引量:16
标识
DOI:10.1111/j.1468-3083.2011.04348.x
摘要

Editor Herpes labialis (HL) is a very frequent disease that affects millions of people. In France, the HERPIMAX study reported a lifetime prevalence of 38.3% and the INSTANT study showed an annual prevalence of 14.8%.1 Although benign, HL is disabling and may have a significant impact on quality of life (QOL) as suggested by Lorette et al.1 The purpose of HERPESCOPE was to describe patients’ profiles, to understand the burden of disease and to assess the impact on QOL, in France and in the US. The HERPESCOPE, conducted by Nielsen, took place in November 2010. The sample was constituted according to the quotas method. All respondents, aged ≥18 years, were screened on having, themselves and/or their child, at least one episode of HL in the past 12 months. Patients having at least one episode in the last 4 weeks completed the QOL – SF-36 questionnaire.2–4 Comparisons were performed between patients with <4 episodes per year (CHL) and those with ≥4 episodes per year (FHL). A group of very frequent HL (VFHL ≥6) was individualized. 1002 and 1005 patients participated in the study and 437 and 476 completed the SF36 questionnaire, in the US and France, respectively. The profile of the patients was very similar to that established in INSTANT study,1 which confirms that there was no bias related to the sample profile (female patients: 59% and 58%, respectively, median class of ages 30–39 years). The mean annual numbers of episodes were high, respectively, 3.6 and 3.4. In both countries, FHL affects 35% of patients suffering from the disease (median of five episodes), and VFHL, 15% of them (median of eight episodes). In both countries, more than 75% of patients declared reacting during the prodromal phase, before redness appears (Table 1). In the US, FHL patients had earlier reactions than CHL patients (NS in France). The management of FHL and CHL patients was different. In both countries, for FHL patients the higher the number of episodes was, the higher the resort to physicians was (more marked in the US). In the US, FHL patients visited a doctor, or used an old prescription, more frequently than CHL patients (57% treated their herpes by themselves). In France, CHL patients asked a pharmacist’s advice (28%). HL episodes lead to frequent sick leaves, with longer durations in FHL groups. Among patients who followed a medical advice to treat their herpes, in US 45% stopped working due to their HL episode (33% with a sick leave, mostly among the FHL group; median duration: 5 and 3 days in the FHL and CHL groups, respectively) and in France 21% (14% with a sick leave; median duration: 5 and 3 days in the FHL and CHL groups, respectively). Quality of life, impaired in more than 80% of cases, is significantly more affected in FHL patients (Table 2). Approximately two-thirds of respondents reported an impact of their physical and/or emotional condition, more pronounced in FHL patients. A majority of patients were disturbed in their social life. Physical pain, reported by more than 90% of patients, was significantly more severe in the FHL groups. Physical pain had a negative effect on work and chores, the impact being significantly higher in FHL patients. Health condition limited patients in physical activity. The majority of patients were regularly tired or exhausted and the perception of their health was impaired in FHL patients. These results are consistent with those obtained in the Lorette study that showed significantly lower QOL scores in subjects with at least six episodes per year. These data reflect the burden of disease associated with HL.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
1秒前
1111完成签到,获得积分10
1秒前
2秒前
楠栎发布了新的文献求助10
2秒前
隐形曼青的应助被陈预立采纳,获得10
3秒前
5秒前
6秒前
6秒前
6秒前
Wuwj完成签到 ,获得积分10
6秒前
清池完成签到 ,获得积分10
8秒前
Cedric完成签到 ,获得积分10
8秒前
NexusExplorer的应助被谨慎的秋烟采纳,获得10
9秒前
奋斗的科学家完成签到,获得积分10
9秒前
忽晚完成签到 ,获得积分10
9秒前
Mao发布了新的文献求助10
9秒前
9秒前
xxdwyd完成签到 ,获得积分10
10秒前
10秒前
科目三的应助被顺利的楷瑞采纳,获得10
11秒前
花儿与少年完成签到,获得积分20
11秒前
华无剑的应助被SGD采纳,获得10
11秒前
11秒前
杜晓倩发布了新的文献求助10
12秒前
xxdwyd关注了科研通微信公众号
14秒前
认真青曼发布了新的文献求助10
14秒前
雪山大地发布了新的文献求助10
15秒前
华仔的应助被暗转采纳,获得10
15秒前
Hello的应助被小元采纳,获得10
15秒前
楠栎完成签到,获得积分10
15秒前
一口一完成签到,获得积分10
16秒前
真找不到发布了新的文献求助10
16秒前
爱你老己完成签到 ,获得积分10
17秒前
逆魔完成签到 ,获得积分10
18秒前
小蘑菇的应助被天然采纳,获得10
18秒前
20秒前
21秒前
24秒前
搜集达人的应助被科研通管家采纳,获得10
25秒前
小马甲的应助被科研通管家采纳,获得10
25秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
plantTFDB 508
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8172605
求助须知:如何正确求助?哪些是违规求助? 9565323
关于积分的说明 21778953
捐赠科研通 7764352
什么是DOI,文献DOI怎么找? 3431411
关于科研通互助平台的介绍 2555301
邀请新用户注册赠送积分活动 2476394